
4 Largecap FY26 and Quarterly Profit Growth with Rising Sales Stocks to Watch for Future Multibagger Potential: UltraTech, Hindustan Zinc, BHEL and Laurus Labs
UltraTech Rs 12,100. Hindustan Zinc Rs 554.85. BHEL Rs 436.30. Laurus Labs Rs 2,424. Market caps from Rs 1.31 lakh crore to Rs 3.57 lakh crore. Data as of 13 Nov 2026.
Updated: 16 Nov 2026 • 10:49 am
Posted by:

Quick Answer
UltraTech, Hindustan Zinc, BHEL and Laurus Labs are the 4 picks in this FY26 and quarterly profit growth with rising sales stocks watchlist, with market caps between Rs 1.31 lakh crore and Rs 3.57 lakh crore. Hindustan Zinc stands out for the highest return on equity at 69.51%, while Hindustan Zinc offers the lowest PE of the group at 11.24. PE ratios run from 11.24 to 98.13, so compare each one with its industry PE before investing. All figures are as of 13 November 2026.
FY26 and quarterly profit growth with rising sales stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. UltraTech, Hindustan Zinc, BHEL and Laurus Labs meet that test, with market caps from Rs 1.31 lakh crore to Rs 3.57 lakh crore and Hindustan Zinc offering the highest return on equity at 69.51%. Each of these companies has FY26 net profit growth of at least 20 per cent, latest-quarter revenue growth of at least 15 per cent year on year, latest-quarter net profit growth of at least 20 per cent year on year, a return on equity of at least 10 per cent, net profit growth in FY26 and in the latest quarter, and market capitalisation above Rs 1,00,000 crore.
This list covers companies with annual and quarterly profit gains and rising quarterly sales, ranked by market capitalisation. Every company has complete, verifiable financials, and investors screening FY26 and quarterly profit growth with rising sales stocks usually begin with size and balance sheet strength, so this list follows the same logic. All figures are as of 13 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are FY26 and Quarterly Profit Growth with Rising Sales Stocks and Why Do They Attract Multibagger Interest?
FY26 and quarterly profit growth with rising sales stocks are shares of companies that clear several growth and quality tests at once: FY26 net profit growth of at least 20 per cent, latest-quarter revenue growth of at least 15 per cent year on year and latest-quarter net profit growth of at least 20 per cent year on year. The 4 here cover cement, heavy electrical equipment, pharmaceutical ingredients and zinc.
A multi-year growth record together with a strong latest year and a rising latest quarter shows that demand for the business is steady and not a one-off spike. Within FY26 and quarterly profit growth with rising sales stocks, all 4 companies show rising profit in FY26 and in the latest quarter, which is the first check most investors make. With FY26 and quarterly profit growth with rising sales stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Anyone shortlisting FY26 and quarterly profit growth with rising sales stocks should compare valuation, growth and balance sheet strength together rather than relying on one number. Read each company's latest results and exchange filings before acting on FY26 and quarterly profit growth with rising sales stocks. The figures for FY26 and quarterly profit growth with rising sales stocks in this article come from NSE and BSE data and company filings, and they are complete for every name shown. Within FY26 and quarterly profit growth with rising sales stocks, the common thread is rising profit backed by complete financial data. Track every result season for FY26 and quarterly profit growth with rising sales stocks, because earnings growth is what supports the share price over time. For FY26 and quarterly profit growth with rising sales stocks, a staggered approach across quarters helps manage valuation risk.
FY26 and Quarterly Profit Growth with Rising Sales Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 13 November 2026. Hindustan Zinc has the lowest PE of the group at 11.24, while Hindustan Zinc posts the highest return on equity at 69.51%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | Dividend Yield |
|---|---|---|---|---|---|---|---|
| UltraTech Cement | 12,100 | 3,56,503 | 40.35 | 36.71 | 11.96% | 4.84 | 1.98% |
| Hindustan Zinc | 554.85 | 2,34,209 | 11.24 | 10.11 | 69.51% | 7.82 | 1.80% |
| Bharat Heavy Electricals | 436.30 | 1,51,574 | 52.64 | 43.77 | 10.76% | 5.67 | 0.32% |
| Laurus Labs | 2,424 | 1,30,756 | 98.13 | 40.65 | 22.11% | 21.57 | 0.08% |
UltraTech: September 2026 Quarter Profit Up 21.28%
UltraTech Cement is the largest cement producer in India by capacity, with plants and grinding units across the country. It reported FY26 revenue of Rs 89,089.04 crore, up 16.15% year on year, and net profit of Rs 8,188.35 crore, up 35.58%. Net profit has compounded at 3.36% a year since FY22, while revenue has grown 13.81% a year. Operating margin was 19.71% in FY26.
In the September 2026 quarter, revenue rose 18.33% to Rs 23,405.96 crore and net profit grew 21.28% to Rs 1,501.38 crore. Domestic institutions raised their holding from 16.65% in September 2025 to 20.86% in September 2026. The stock trades at a PE of 40.35 against an industry PE of 36.71, with a return on equity of 11.96% and a price to book of 4.84.
Hindustan Zinc: September 2026 Quarter Profit Up 142.05%
Hindustan Zinc is among the world's largest integrated zinc producers and also produces lead and silver. It reported FY26 revenue of Rs 41,934 crore, up 19.59% year on year, and net profit of Rs 13,832 crore, up 33.60%. Net profit has compounded at 9.48% a year since FY22, while revenue has grown 8.15% a year. Operating margin was 56.75% in FY26. The debt-to-equity ratio is 0.22, which keeps interest costs low.
In the September 2026 quarter, revenue rose 76.02% to Rs 15,467 crore and net profit grew 142.05% to Rs 6,412 crore. Foreign investors raised their holding from 1.31% in September 2025 to 2.36% in September 2026. The stock trades at a PE of 11.24 against an industry PE of 10.11, with a return on equity of 69.51% and a price to book of 7.82.
BHEL: September 2026 Quarter Profit Up 118.98%
Bharat Heavy Electricals is a government-owned maker of power generation, transmission, industrial and transportation equipment. It reported FY26 revenue of Rs 34,589.83 crore, up 20.08% year on year, and net profit of Rs 1,600.26 crore, up 199.73%. Net profit has compounded at 37.73% a year since FY22, while revenue has grown 12.54% a year. Operating margin was 10.18% in FY26. The debt-to-equity ratio is 0.23, which keeps interest costs low.
In the September 2026 quarter, revenue rose 24.28% to Rs 9,553.01 crore and net profit grew 118.98% to Rs 820.94 crore. Foreign investors raised their holding from 6.23% in September 2025 to 9.94% in September 2026. The stock trades at a PE of 52.64 against an industry PE of 43.77, with a return on equity of 10.76% and a price to book of 5.67.
Laurus Labs: September 2026 Quarter Profit Up 125.41%
Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Net profit has compounded at 1.68% a year since FY22, while revenue has grown 8.53% a year. Operating margin was 26.90% in FY26.
In the September 2026 quarter, revenue rose 32.07% to Rs 2,219.38 crore and net profit grew 125.41% to Rs 436.74 crore. Foreign investors raised their holding from 26.16% in September 2025 to 30.84% in September 2026. The stock trades at a PE of 98.13 against an industry PE of 40.65, with a return on equity of 22.11% and a price to book of 21.57.
FY26 and Quarterly Profit Growth with Rising Sales Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these FY26 and quarterly profit growth with rising sales stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | 4-Year Net Profit CAGR | Latest Quarter Profit Growth (YoY) |
|---|---|---|---|---|---|---|
| UltraTech | 89,089.04 | 8,188.35 | 16.15% | 13.81% | 3.36% | 21.28% |
| Hindustan Zinc | 41,934 | 13,832 | 19.59% | 8.15% | 9.48% | 142.05% |
| BHEL | 34,589.83 | 1,600.26 | 20.08% | 12.54% | 37.73% | 118.98% |
| Laurus Labs | 6,867.85 | 889.85 | 22.01% | 8.53% | 1.68% | 125.41% |
Institutional Holding in UltraTech, Hindustan Zinc, BHEL and Laurus Labs
Institutional holding shows who is backing these FY26 and quarterly profit growth with rising sales stocks alongside the promoter. The table uses the latest reported quarter for each. Laurus Labs has the deepest institutional backing, with FII and DII together holding 42.70% as of September 2026. Domestic institutions increased their holding over the past year in UltraTech (from 16.65% to 20.86%) and BHEL (from 18.62% to 21.88%). To see how this group fits the wider market, many investors compare it with the Nifty 50.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| UltraTech | 58.48% | 12.69% | 20.86% | 7.97% | September 2026 |
| Hindustan Zinc | 60.71% | 2.36% | 4.85% | 32.07% | September 2026 |
| BHEL | 58.17% | 9.94% | 21.88% | 10.02% | September 2026 |
| Laurus Labs | 27.47% | 30.84% | 11.86% | 29.83% | September 2026 |
Risks to Weigh in FY26 and Quarterly Profit Growth with Rising Sales Stocks
Being careful with FY26 and quarterly profit growth with rising sales stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Laurus Labs trades at a PE of 98.13 against an industry PE of 40.65, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one theme, so size each position to match your risk appetite.
How to Choose Between FY26 and Quarterly Profit Growth with Rising Sales Stocks
Picking from FY26 and quarterly profit growth with rising sales stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (10.11 to 43.77) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track UltraTech, Hindustan Zinc, BHEL and Laurus Labs live prices.
Conclusion
Among FY26 and quarterly profit growth with rising sales stocks, Hindustan Zinc stands out for the highest return on equity at 69.51%, Hindustan Zinc for the lowest PE of the group at 11.24, BHEL for the fastest profit compounding at 37.73% a year since FY22 and Hindustan Zinc for the sharpest latest-quarter profit growth at 142.05%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing FY26 and quarterly profit growth with rising sales stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on FY26 and Quarterly Profit Growth with Rising Sales Stocks to Watch
Which are the best FY26 and quarterly profit growth with rising sales stocks to watch for multibagger potential?
Ans. UltraTech, Hindustan Zinc, BHEL and Laurus Labs are the 4 names this list highlights, with market caps of Rs 3,56,503 crore, Rs 2,34,209 crore, Rs 1,51,574 crore and Rs 1,30,756 crore respectively. Hindustan Zinc is notable for the highest return on equity at 69.51%. Hindustan Zinc stands out for the lowest PE of the group at 11.24. BHEL offers the fastest profit growth, 37.73% a year since FY22. Hindustan Zinc brings the sharpest latest-quarter profit growth at 142.05%. These are watchlist names for FY26 and quarterly profit growth with rising sales stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Hindustan Zinc a good stock for long-term investors?
Ans. Hindustan Zinc has a return on equity of 69.51%, a PE of 11.24 against an industry PE of 10.11 and a market cap of Rs 2,34,209 crore. Net profit has compounded at 9.48% a year since FY22, and FY26 revenue rose 19.59% while September 2026 quarter net profit grew 142.05%. Long-term returns in FY26 and quarterly profit growth with rising sales stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can UltraTech become a multibagger from here?
Ans. A multibagger outcome in FY26 and quarterly profit growth with rising sales stocks requires earnings to keep growing faster than the market for several years. UltraTech has grown revenue at 13.81% a year since FY22 and net profit at 3.36% a year, and FY26 revenue rose 16.15%. At a PE of 40.35 against an industry PE of 36.71, valuation should be checked against that growth before investing, and no outcome is guaranteed.
What is the market cap of UltraTech, Hindustan Zinc, BHEL and Laurus Labs?
Ans. As of 13 November 2026, UltraTech has a market cap of Rs 3,56,503 crore, Hindustan Zinc has a market cap of Rs 2,34,209 crore, BHEL has a market cap of Rs 1,51,574 crore and Laurus Labs has a market cap of Rs 1,30,756 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on FY26 and quarterly profit growth with rising sales stocks.
What are the risks of investing in FY26 and quarterly profit growth with rising sales stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Laurus Labs trades at a PE of 98.13 against an industry PE of 40.65, so earnings growth needs to hold up. Diversifying across the 4 names and reviewing each quarterly result helps keep risk in check.
Why is Laurus Labs trading at a PE of 98.13?
Ans. Laurus Labs's PE of 98.13 compares with an industry PE of 40.65. The market is paying a premium for a return on equity of 22.11%, profit growth of 1.68% a year since FY22 and latest-quarter profit growth of 125.41%, which also means the stock is more sensitive if growth slows. Investors in FY26 and quarterly profit growth with rising sales stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in UltraTech, Hindustan Zinc, BHEL and Laurus Labs?
Ans. As of the latest reported quarter, FII and DII together hold 33.55% of UltraTech (12.69% and 20.86%), 7.21% of Hindustan Zinc (2.36% and 4.85%), 31.82% of BHEL (9.94% and 21.88%) and 42.70% of Laurus Labs (30.84% and 11.86%). Rising institutional holding is a useful signal in FY26 and quarterly profit growth with rising sales stocks, though it should be read with earnings trends rather than on its own.
Recent Articles

4 Midcap Revenue Compounders Quarterly Sales and Profit Growth Stocks to Watch for Future Multibagger Potential: Uno Minda, Apar Industries, Sona BLW and Navin Fluorine
16 November 2026

4 Largecap Revenue Compounders Quarterly Sales and Profit Growth Stocks to Watch for Future Multibagger Potential: Bajaj Finserv, Trent, Cholamandalam and CG Power
16 November 2026

4 Largecap FII Favourite Quarterly Sales and Profit Growth Stocks to Watch for Future Multibagger Potential: Bajaj Finance, L&T, M&M and BSE
16 November 2026

4 Smallcap FY26 and Quarterly Profit Growth with Rising Sales Stocks to Watch for Future Multibagger Potential: Kajaria Ceramics, Avalon, VA Tech Wabag and Shipping Corporation
16 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
4 Midcap Revenue Compounders Quarterly Sales and Profit Growth Stocks to Watch for Future Multibagger Potential: Uno Minda, Apar Industries, Sona BLW and Navin Fluorine
4 Largecap Revenue Compounders Quarterly Sales and Profit Growth Stocks to Watch for Future Multibagger Potential: Bajaj Finserv, Trent, Cholamandalam and CG Power
4 Largecap FII Favourite Quarterly Sales and Profit Growth Stocks to Watch for Future Multibagger Potential: Bajaj Finance, L&T, M&M and BSE
4 Smallcap FY26 and Quarterly Profit Growth with Rising Sales Stocks to Watch for Future Multibagger Potential: Kajaria Ceramics, Avalon, VA Tech Wabag and Shipping Corporation
4 Smallcap Promoter Backed Revenue Compounders Quarterly Sales Growth Stocks to Watch for Future Multibagger Potential: Capri Global, JBM Auto, PN Gadgil and Power Mech

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





